Fairfield Market Research Prefilled Syringes Market Size, Share, Report, Trends, Type 2029

Prefilled Syringes Market

Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Published Date: Upcoming | Format:

Industry: Medical Devices

Request TOC Request Customization $4,995.00Prebook

Growing Need for Safer and More Convenient Drug Delivery Boosts Demand for Prefilled Syringes

Advanced technology, improved drug delivery methods continue to emerge popular in tandem with the transformation of pharmaceutical industry as it undergoes consistent sophistication. One of the most breakthrough shifts the industry has witnessed is that from the traditional glass syringes to disposable plastic syringes and further to prefilled syringes (PFS). Being a single-dose packet of preparation, prefilled syringes are used to package injectable drugs and diluents, and are considered safer as they are disposed after one use.

Besides safe and convenient packing of parenteral drugs, prefilled syringes are being increasingly considered for packaging of some other product categories as well, including vaccines, blood stimulants, therapeutic proteins, erythroproteins, and interferons. Surging demand for sterile, convenient, accurate, and affordable parenteral drug delivery is fostering sales of prefilled syringes in global market.

User-friendly Features and Accurate Dosage Make Prefilled Syringes Ideal for Self-administration

Compounded sterile preparations (CSPs) can reduce the risk of microbial ingress and product cross contamination, thereby improving patient safety. Prefilled syringes contain the exact dose unlike vials that are overfilled up to 25%, which helps in eliminating dosing errors. Prefilled syringes essentially omit the processes required before one uses a drug in a vial.

With the advent of biotechnology drugs that are priced at an expensive point, prefilled syringes have come up as a boon as they promote lesser waste, which is advantageous in case of vaccine shortages and expensive drugs. Pharmaceutical companies can increase a product’s life span while patients can self-administer injectable drugs at home. Prefilled syringes are better equipped in emergency situations and serve as an ideal drug delivery solution in remote areas. They readily aid in self-administration of monoclonal antibodies used in multiple chronic conditions, which is another strong factor supporting the growth of prefilled syringes market.

Stability and Safety Issues Remain Longstanding Challenges Facing Prefilled Syringes Market Players

Amid escalating consumption of prefilled syringes within pharma and medical industries, manufacturers ought to ensure that the primary packaging does not have an adverse interaction with drugs. Any kind of interaction of prefilled syringes with drugs leads to stability issues - extractables and leachables (E&L) can interfere with drug molecules (in contact with not only the drug, but more materials and components), eventually resulting in compromised effectiveness of the concerned drugs. Such accidents lead to severe processing and quality control issues, which still remain a challenge to rapid growth of prefilled syringes market. Moreover, development of cost-effective alternatives and eliminating the odds of needle stick injuries will continue to be the concerning issues for manufacturers of prefilled syringes.

Simple Storage and Disposal Requisites Paving Way for Single-chamber Prefilled Syringes

Single-chamber prefilled syringes will flourish in terms of demand in the near future owing to their simple and convenient storage and disposal requisites, lesser drug waste during clinical trials, reduced material requirement, and optimized active pharmaceutical ingredient (API) use to prevent the overfill. Single-chamber prefilled syringes are significantly gaining from the brisk expansion of home healthcare settings over the past decade. Improved acceptance to self-administration of routine drugs among chronic disease patients is also largely responsible for the progress of global prefilled syringes market. Rising adoption of self-administered parenteral drugs and escalating prevalence of chronic diseases are thus collectively contributing to climbing sales of prefilled syringes in global market.

European Market Flourishes under All Favourable Circumstances

North American and European markets remain at the forefront of demand in global prefilled syringes landscape. While these developed regions lead their way on the back of frequent and greater number of product launches, they also seem to be benefitting from stronger distribution networks of key marketers. European markets are particularly performing better with increasing adoption of prefilled syringes as self-injecting drug devices, increases consumption of biologics and biosimilars, and growing investments from leading industry players in the region. Strong efforts of regional players in geographical expansion also work in favour of market growth.

Recently in 2021, Schreiner MediPharm – a Germany-based innovative functional label solutions provider has developed a first of its kind new tamper-proof Syringe-Closure-Wrap to deliver clear first-opening indication for pre-filled syringes. The solution ultimately aims to preserve the probity of prefilled syringes that would eventually translate into much improved patient safety.

BD Dominant in Prefilled Syringes Landscape; R&D Investments Picking up among Key Players

Becton, Dickinson and Company (BD) has been holding a controlling share in global prefilled syringes market banking on its broad product portfolio, wide customer base, and strong geographical presence. The company recently made an announcement about its US$ 1.2 billion investment in expanding the prefilled syringes manufacturing capacity by 50%. This investment is directed to a new plant based in Europe in addition to selective advancements in the company’s existing plants at six locations in the US, Europe, Japan, and Mexico.

Baxter International Inc., Catalent Inc., Elcam Medical ACS. Ltd, Gerresheimer AG, Nipro Medical Corporation, Oval Medical Technologies Limited, SHL Medical AG, Stevanato Group, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, West Pharmaceutical Services, Inc., and Ypsomed Group are some of the most prominent players actively participating in global prefilled syringes market landscape. Companies are focusing on R&D investments in an effort to keep up with frequent biotech and pharma innovations. The market is also witnessing growing emphasis on syringe modification strategies. Companies are further concentrating on development of newer distribution channels and including value added services under their existing offerings.

Key Elements Included In The Study: Global Prefilled Syringes Market

  • Prefilled Syringes Market by Product/Technology/Grade, Application/End-user, and Region
  • Executive Summary (Opportunity Analysis and Key Trends)
  • Historical Market Size and Estimates, Value, 2018 - 2021
  • Market Value at Regional and Country Level, 2022 - 2029
  • Market Dynamics and Economic Overview
  • Market Size in Value, Growth Rates, and Forecast Figures, 2022 - 2029
  • Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies 
  • Regional and Product/Grade/Application/End-user Price Trends Analysis
  • Value Chain and Five Force’s Analysis
  • Regional/Sub-region/Country Market Size and Trend Analysis
  • Company Market Share Analysis and Key Player Profiles

Post Sale Support, Research Updates & Offerings

We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.

  • The report will be prepared in a PPT format and will be delivered in a PDF format.
  • Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.
  • If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.
  • If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.
  • If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.


  • The segmentation/company profiles/countries depicted above may vary in the actual report.

Request Table of Contents

Our Research Methodology

Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.

View Methodology
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services